Critical Respiratory Events in Children Requiring Naloxone: Naloxone Use as Opioid Safety Measure
Study of Hospital-wide Critical Respiratory Events Requiring Naloxone in a Pediatric Institution
1 other identifier
observational
95
1 country
1
Brief Summary
Opioids are the mainstay of analgesia in hospitalized children but opioid therapy is associated with life-threatening respiratory depression requiring antagonism with naloxone. Hence, it is hypothesized that naloxone requirement can be used as a quality measure of opioid safety. A retrospective medical chart review of 95 patients, who received naloxone for life threatening events, from June 2006-2012, is planned, to identify significant factors associated with risk for opioid induced respiratory depression and formulation of preventive strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 15, 2013
CompletedFirst Posted
Study publicly available on registry
May 23, 2013
CompletedMay 23, 2013
May 1, 2013
9 months
May 15, 2013
May 21, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Descriptive: Medical history and Risk Factors for critical respiratory events requiring Naloxone in children
Data leading to the event and post-event descriptives will be collected
about 6 hours around the event
Study Arms (1)
Patients requiring naloxone for respiratory depression
Eligibility Criteria
All patients who required rescue with naloxone between June 2006 and June 2012; identified based upon an automated trigger report generated from the hospital's risk management database for any dispensation of naloxone from the hospital pharmacy
You may qualify if:
- any gender, age or race
- administered naloxone for opioid induced respiratory depression
You may not qualify if:
- Any one who did not require naloxone for opioid induced respiratory depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2013
First Posted
May 23, 2013
Study Start
August 1, 2012
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
May 23, 2013
Record last verified: 2013-05